Zobrazeno 1 - 10
of 14
pro vyhledávání: '"María Vanesa Hernández Hernández"'
Autor:
Alicia García-Dorta, Paola León-Suarez, Sonia Peña, Marta Hernández-Díaz, Carlos Rodríguez-Lozano, Enrique González-Dávila, María Vanesa Hernández-Hernández, Federico Díaz-González
Publikováno v:
Frontiers in Medicine, Vol 8 (2022)
Background: Secukinumab has been shown effective for psoriatic arthritis (PsA) and axial spondylarthritis (AxSpA) in randomized trials. The aim of this study was to analyze baseline patient and disease characteristics associated with a better retenti
Externí odkaz:
https://doaj.org/article/d8d4035f430344a9b1bf807e8bb7e851
Autor:
Cristina Almeida-Santiago, Juan Carlos Quevedo-Abeledo, María Vanesa Hernández-Hernández, Antonia de Vera-González, Alejandra González-Delgado, Miguel Ángel González-Gay, Iván Ferraz-Amaro
Publikováno v:
Life, Vol 13, Iss 1, p 82 (2022)
Interleukin-1 receptor antagonist (IL-1ra) concentration reflects and is proportional to IL-1 production. Both IL-1 and IL-6 are involved in the pathogenesis of rheumatoid arthritis (RA). However, the relationship of serum levels of these two cytokin
Externí odkaz:
https://doaj.org/article/c33551da281c4c55a3e6ce7bf96a0fcb
Autor:
Javier Narváez, Petra Díaz del Campo Fontecha, Noé Brito García, Gema Bonilla, Myriam Aburto, Iván Castellví, Esteban Cano-Jiménez, Natalia Mena-Vázquez, M. Asunción Nieto, Ana María Ortiz, Claudia Valenzuela, Miguel Ángel Abad Hernández, Isabel Castrejón, María Correyero Plaza, Félix Manuel Francisco Hernández, María Vanesa Hernández Hernández, José Antonio Rodríquez Portal
Publikováno v:
Reumatología Clínica. 18:501-512
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e4e99961791668617760bbba3a21a9a
https://doi.org/10.1016/j.reuma.2022.03.005
https://doi.org/10.1016/j.reuma.2022.03.005
Autor:
Javier Narváez, Petra Díaz del Campo Fontecha, Noé Brito García, Gema Bonilla, Myriam Aburto, Iván Castellví, Esteban Cano-Jiménez, Natalia Mena-Vázquez, M. Asunción Nieto, Ana María Ortiz, Claudia Valenzuela, Miguel Ángel Abad Hernández, Isabel Castrejón, María Correyero Plaza, Félix Manuel Francisco Hernández, María Vanesa Hernández Hernández, José Antonio Rodríquez Portal
Publikováno v:
Reumatología Clínica (English Edition). 18:501-512
To develop multidisciplinary recommendations to improve the management of rheumatoid arthritis-related interstitial lung disease (RA-ILD).Clinical research questions relevant to the objective of the document were identified by a panel of rheumatologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88b114093431dc983c239b62a69d8552
https://doi.org/10.1016/j.reumae.2022.03.004
https://doi.org/10.1016/j.reumae.2022.03.004
Autor:
José Antonio Rodríguez Portal, Noé Brito García, Petra Díaz del Campo Fontecha, Claudia Valenzuela, Ana María Ortiz, M. Asunción Nieto, Natalia Mena-Vázquez, Esteban Cano-Jiménez, Iván Castellví, Myriam Aburto, Gema Bonilla, María Vanesa Hernández Hernández, Félix Manuel Francisco Hernández, María Correyero Plaza, Isabel Castrejón, Miguel Ángel Abad Hernández, Javier Narváez
Publikováno v:
Reumatología Clínica (English Edition). 18:443-452
To develop multidisciplinary recommendations to improve the management of rheumatoid arthritis-related interstitial lung disease (RA-ILD).Clinical research questions relevant to the objective of the document were identified by a panel of rheumatologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e953140d9f1099dfefa37604cb3f8b8
https://doi.org/10.1016/j.reumae.2022.02.004
https://doi.org/10.1016/j.reumae.2022.02.004
Autor:
José Antonio Rodríguez Portal, Noé Brito García, Petra Díaz del Campo Fontecha, Claudia Valenzuela, Ana María Ortiz, M. Asunción Nieto, Natalia Mena-Vázquez, Esteban Cano-Jiménez, Iván Castellví, Myriam Aburto, Gema Bonilla, María Vanesa Hernández Hernández, Félix Manuel Francisco Hernández, María Correyero Plaza, Isabel Castrejón, Miguel Ángel Abad Hernández, Javier Narváez
Publikováno v:
Reumatología Clínica. 18:443-452
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d9bbc712a9331a5e565ce7d37364cdf
https://doi.org/10.1016/j.reuma.2022.02.009
https://doi.org/10.1016/j.reuma.2022.02.009
Autor:
Federico Díaz-González, Iván Ferraz-Amaro, María Vanesa Hernández-Hernández, Hiurma Sánchez-Pérez, Estefanía Armas-González, José David Machado
Publikováno v:
Clinical Rheumatology. 39:1871-1880
Cholesterol efflux capacity (CEC) is the ability of high-density lipoprotein (HDL) cholesterol to accept cholesterol from macrophages. CEC is linked to cardiovascular events in the general population, and it has been shown to be disrupted in inflamma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f463934f6483f5a24241782f58caa5a5
https://doi.org/10.1007/s10067-020-04961-4
https://doi.org/10.1007/s10067-020-04961-4
Autor:
Alicia García-Dorta, Paola León-Suarez, Sonia Peña, Marta Hernández-Díaz, Carlos Rodríguez-Lozano, Enrique González-Dávila, María Vanesa Hernández-Hernández, Federico Díaz-González
Publikováno v:
Frontiers in Medicine
Frontiers in Medicine, Vol 8 (2022)
Frontiers in Medicine, Vol 8 (2022)
Background: Secukinumab has been shown effective for psoriatic arthritis (PsA) and axial spondylarthritis (AxSpA) in randomized trials. The aim of this study was to analyze baseline patient and disease characteristics associated with a better retenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abbfb23108b9e65b3b090c162c4cbd81
https://pubmed.ncbi.nlm.nih.gov/35096907
https://pubmed.ncbi.nlm.nih.gov/35096907
Autor:
Hiurma Sánchez-Pérez, Federico Díaz-González, Iván Ferraz-Amaro, Cristina Luna-Gómez, María Vanesa Hernández-Hernández
Publikováno v:
Arthritis careresearchREFERENCES. 73(12)
The purpose of this study was to compare physical activity (PA) in a group of patients with psoriatic arthritis (PsA) versus healthy controls and to determine whether the mobility of these patients is affected by disease activity.A group of 52 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f81d104961c36a9631bbea500e895925
https://pubmed.ncbi.nlm.nih.gov/33242378
https://pubmed.ncbi.nlm.nih.gov/33242378
Autor:
Iván, Ferraz-Amaro, María Vanesa, Hernández-Hernández, Estefanía, Armas-González, Hiurma, Sánchez-Pérez, José David, Machado, Federico, Díaz-González
Publikováno v:
Clinical rheumatology. 39(6)
Cholesterol efflux capacity (CEC) is the ability of high-density lipoprotein (HDL) cholesterol to accept cholesterol from macrophages. CEC is linked to cardiovascular events in the general population, and it has been shown to be disrupted in inflamma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e6eba2f530968f531be0b63d79cbefa1
https://pubmed.ncbi.nlm.nih.gov/31993889
https://pubmed.ncbi.nlm.nih.gov/31993889